日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of Tezepelumab on the Humoral Immune Response to Seasonal Quadrivalent Influenza Vaccination in Patients with Moderate to Severe Asthma: The Phase 3b VECTOR Study

Tezepelumab 对中重度哮喘患者接种季节性四价流感疫苗后体液免疫反应的影响:VECTOR 3b 期研究

Cole, Jeremy; Cąpała-Szczurko, Iwona; Roseti, Stephanie; Chen, Claudia; Caveney, Scott; Aksyuk, Anastasia A; Streicher, Katie; Ponnarambil, Sandhia; Colice, Gene

Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials

Tezepelumab治疗重度难治性哮喘的疗效:PATHWAY和NAVIGATOR临床试验的汇总分析

Corren, Jonathan; Menzies-Gow, Andrew; Chupp, Geoffrey; Israel, Elliot; Korn, Stephanie; Cook, Bill; Ambrose, Christopher S; Hellqvist, Åsa; Roseti, Stephanie L; Molfino, Nestor A; Llanos, Jean-Pierre; Martin, Neil; Bowen, Karin; Griffiths, Janet M; Parnes, Jane R; Colice, Gene

Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study

在 NAVIGATOR 3 期研究中,Tezepelumab 对重度、未控制哮喘患者肺功能的影响

Menzies-Gow, Andrew; Ambrose, Christopher S; Colice, Gene; Hunter, Gillian; Cook, Bill; Molfino, Nestor A; Llanos, Jean-Pierre; Israel, Elliot

Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.

重度哮喘患者基线 2 型生物标志物水平及对 tezepelumab 的反应

Corren Jonathan, Pham Tuyet-Hang, Garcia Gil Esther, Sałapa Kinga, Ren Pin, Parnes Jane R, Colice Gene, Griffiths Janet M

Targeting TSLP in Asthma

以TSLP为靶点治疗哮喘

Parnes, Jane R; Molfino, Nestor A; Colice, Gene; Martin, Ubaldo; Corren, Jonathan; Menzies-Gow, Andrew

Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study

Tezepelumab 可降低重度、未控制哮喘患者各季节的哮喘急性发作:PATHWAY 2b 期研究的事后分析

Corren, Jonathan; Karpefors, Martin; Hellqvist, Åsa; Parnes, Jane R; Colice, Gene

Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study

Tezepelumab治疗伴或不伴鼻息肉的重度难治性哮喘患者的疗效:PATHWAY 2b期研究的事后分析

Emson, Claire; Corren, Jonathan; Sałapa, Kinga; Hellqvist, Åsa; Parnes, Jane R; Colice, Gene

Functionality and Performance of an Accessorized Pre-Filled Syringe and an Autoinjector for At-Home Administration of Tezepelumab in Patients with Severe, Uncontrolled Asthma

用于治疗重度、未控制哮喘患者的 Tezepelumab 居家给药的辅助预充式注射器和自动注射器的功能和性能

Alpizar, Sady; Megally, Ayman; Chen, Claudia; Raj, Abhi; Downie, John; Colice, Gene

CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma

CASCADE:一项 II 期随机、双盲、安慰剂对照、平行组试验,旨在评估 tezepelumab 对未控制哮喘患者气道炎症的影响

Emson, Claire; Diver, Sarah; Chachi, Latifa; Megally, Ayman; Small, Cherrie; Downie, John; Parnes, Jane R; Bowen, Karin; Colice, Gene; Brightling, Chris E

SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma

来源:一项评估tezepelumab在减少口服糖皮质激素依赖型哮喘成人患者口服糖皮质激素用量方面的疗效和安全性的3期、多中心、随机、双盲、安慰剂对照、平行组试验

Wechsler, Michael E; Colice, Gene; Griffiths, Janet M; Almqvist, Gun; Skärby, Tor; Piechowiak, Teresa; Kaur, Primal; Bowen, Karin; Hellqvist, Åsa; Mo, May; Garcia Gil, Esther